Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

COLLEGE PARK, Maryland--(BUSINESS WIRE)--IonQ (NYSE: IONQ), ein führendes Unternehmen in der Quantencomputer- und Netzwerkbranche, veröffentlichte heute Ergebnisse eines von IonQ,…

Mercks shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.…

If everyone only invested in what they fully understood, I suspect quite a few stocks wouldnt exist today. We can…

…

Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, Medicare patients.…

Astrazeneca (AZN) closed the most recent trading day at $71.93, moving -1.24% from the previous trading session.…

2 June 2025 Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure…

Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds…

DHR and AstraZeneca team up to develop AI-powered diagnostics, aiming to boost precision medicine by improving patient selection and making…

Extending the more-than-4% slide that they experienced last week, shares of Tempus AI (NASDAQ: TEM) have suffered an even more…

…

Shares of Tempus AI (NASDAQ: TEM) are falling on Wednesday. One of Cathie Woods largest holdings, the companys stock plummeted…

Lilly dominates GLP-1 market but faces near-term headwinds, while AstraZeneca boasts steady growth, rising estimates and a higher dividend yield.…

AstraZeneca wins CHMP nod for Imfinzi combo in muscle-invasive bladder cancer, based on data from the phase III NIAGARA study.…

…